Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jun 09, 2022 8:36pm
272 Views
Post# 34745720

Why the Move Today?

Why the Move Today?These are the highlights from Rob's interview on Proactive ....why wouldn't the sp move after the following:

* expecting FDA EUA for AcuVid
* multiple groups interested in AcuVid but waiting on FDA EUA before purchasing through CE mark
* one group proposing to purchase through the CE mark without and before FDA EUA ("decent" order)
* this week (tomorrow?) to finalize and submit application to HC
* meeting with DME Authority to go over sales forecast for Venowave next week

It appears that Rob's status overview and the timeframes he proposed may have been just the catalyst to bring new investors into the fold. Some indifference and retracement this afternoon was good to "fill any holes".

Let this move slow, steady and sustainably. It should be an interesting day tomorrow.

GLTE!!!
<< Previous
Bullboard Posts
Next >>